Who owns Anika Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ANIK from SEC Form 13F filings across 135 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 135 institutions disclosed 12.4M shares of Anika Therapeutics, Inc. worth $172.0M — about 92.7% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
135
13F holders
$172.0M
value, 2026 filers
92.7%
of shares outstanding (12.4M sh)
22
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of ANIK's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 1.4M | $21.2M | 0.0% | 10.9% | -9.1% |
| 2 | Caligan Partners LP | 1.4M | $21.0M | 1.0% | 10.8% | 0.0% |
| 3 | MORGAN STANLEY | 614,320 | $9.0M | 0.0% | 4.6% | -29.6% |
| 4 | ACADIAN ASSET MANAGEMENT LLC | 606,544 | $8,866 | 0.0% | 4.6% | 0.0% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 572,113 | $8.4M | 0.0% | 4.3% | -5.6% |
| 6 | AQR CAPITAL MANAGEMENT LLC | 559,846 | $8.2M | 0.0% | 4.2% | +105.6% |
| 7 | BOOTHBAY FUND MANAGEMENT, LLC | 529,640 | $7.7M | 0.1% | 4% | 0.0% |
| 8 | RENAISSANCE TECHNOLOGIES LLC | 481,417 | $7.0M | 0.0% | 3.6% | -4.1% |
| 9 | DIMENSIONAL FUND ADVISORS LP | 451,095 | $6.6M | 0.0% | 3.4% | -1.7% |
| 10 | CAPITAL MANAGEMENT CORP /VA | 448,474 | $6.6M | 1.0% | 3.4% | +0.2% |
| 11 | DEUTSCHE BANK AG\ | 353,552 | $5.2M | 0.0% | 2.7% | +0.1% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 331,577 | $4.9M | 0.0% | 2.5% | +0.5% |
| 13 | STATE STREET CORP | 311,896 | $4.6M | 0.0% | 2.3% | -9.9% |
| 14 | TWO SIGMA INVESTMENTS, LP | 252,964 | $3.7M | 0.0% | 1.9% | +7.1% |
| 15 | D. E. Shaw & Co., Inc. | 245,066 | $3.6M | 0.0% | 1.8% | +6.6% |
| 16 | GOLDMAN SACHS GROUP INC | 237,722 | $3.5M | 0.0% | 1.8% | +9.1% |
| 17 | JACOBS LEVY EQUITY MANAGEMENT, INC | 217,530 | $3.2M | 0.0% | 1.6% | -18.1% |
| 18 | Nuveen, LLC | 156,538 | $2.3M | 0.0% | 1.2% | +29.7% |
| 19 | Quantinno Capital Management LP | 155,257 | $2.3M | 0.0% | 1.2% | +23.4% |
| 20 | UBS Group AG | 145,816 | $2.1M | 0.0% | 1.1% | +9.6% |
| 21 | Man Group plc | 140,712 | $2.1M | 0.0% | 1.1% | +13.2% |
| 22 | Hillsdale Investment Management Inc. | 138,821 | $2.0M | 0.0% | 1% | +446.5% |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 113,374 | $1.7M | 0.0% | 0.9% | -0.9% |
| 24 | Sixth Street Partners Management Company, L.P.NEW | 113,374 | $1.7M | 0.3% | 0.9% | new |
| 25 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 106,644 | $1.6M | 0.0% | 0.8% | +240.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.